Barclays Maintains Overweight on SNV - PT $65

Jared Shaw— BarclaysSNVVisible Alpha

Received

4/9/2026, 7:14:00 PM

Published

7/28/2025, 12:00:00 AM

Summarized

4/9/2026, 7:14:00 PM

AI Summary

**Rating:** Overweight (Maintained)\n**Price Target:** $65 (from $70)\n**Analyst:** Jared Shaw, Barclays\n\nShaw stayed bullish but flagged merger execution risk. His concern about Southeast MOEs is notable context.

Full Report Content (107 characters)

Barclays maintained Overweight, lowered PT from $70 to $65. Shaw noted MOEs in Southeast tough to pull off.

Metadata

{
  "action": "maintains",
  "rating": "overweight",
  "price_target": 65,
  "prev_price_target": 70
}